Presenter: James McCormack BSc (Pharm) Pharm D Mike Allan MD Mike Kolber MD
0:00
In episode 442, James and Mike welcome back Mike Kolber to discuss all the evidence around biosimilars. The issue is exactly the same one we have had for decades with the question around brand name versus generic medications. Tune in and find out the answer. At the conclusion of this activity, participants will be able…
Latest Podcasts
BS Medicine Episode 630: Vitamin B12 Deficiency: Monthly shots or daily pills?
In episode 630, Jamie and James invite Karenn Chan back to the podcast and we go over all the evidence to answer the question, is giving oral vitamin B12 as…
BS Medicine Episode 629: Deprescribing Cholinesterase Inhibitors: Good or bad idea?
In episode 629, Jamie and James invite Karenn Chan to the podcast for the first time. We go over the evidence for the very important topic of if and when…
CFP Podcast: Heart of patient-centred care is at home
Join CFP Editor Dr. Nick Pimlott and Associate Editor Dr. David Ponka as they explore the power and the value of seeing patients at home with Dr. Sarah Newbery from…
May 26, 2021
Presenter(s):
James McCormack BSc (Pharm) Pharm D Mike Allan MD Mike Kolber MD
Please provide any additional comments (optional).